drugset / Trial / NCT00796263

Antiretroviral Therapy for Acute and Chronic HIV Infection

NCT00796263

Phase 3 Recruiting 900 enrolled SEARCH Research Foundation ViiV Healthcare · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose for this protocol is to provide safe and effective standard ART to SEARCH 010 and SEARCH 013 participants. Participants are enrolled in an acute HIV infection study (SEARCH 010 protocol: 'Establish and characterize an acute HIV infection cohort in a Thai high-risk population') or in a study of chronic HIV infection (SEARCH 013 protocol 'Characteristics of immunity in gut mucosa, spinal fluid, lymph node and blood of HIV negative and HIV positive Thais').

Timeline

Start
2009-05-13
Primary completion
2033-06
Completion
2033-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Abacavir Other / unclassified
Subject Dolutegravir Other / unclassified 50 mg Oral
Subject Lamivudine Other / unclassified